MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

Displaying 1..10 of 13 - per page Next page
Order by
This article considers the potential impact for the international pharmaceutical and biotechnology industries of decisions from a US and a UK court given within a week of each other in October 2004. More
The Cooperative Research and Technology Enhancement ("CREATE") Act of 2004 was signed into law by President Bush on December 10, 2004. More
The Indian pharmaceutical market is due for a paradigm shift on January 1st 2005, when the country falls into line with the World Trade Organisation's TRIPs (Trade-Related aspects of Intellectual Property rights) agreement. More
The UK Department of Trade and Industry is seeking industry More
The 'Harvard Oncomouse' patent claimed a method for producing transgenic non-human mammals with a predisposition to developing cancer. The prospect of the commercialisation of animals fated to develop cancer was the cause of significant protest. More
The University of California at San Francisco claims credit for identification of the DNA of the human growth hormone. Genentech was alleged to have taken and used the University's actual DNA invention without permission. More
A Critical Analysis of the (Non)-Patentability of Diagnostic Methods and Consequences For BRCA1 Gene Type Patents in Europe More
Scientific progress depends on the publication of results while industry needs patents to protect its investment, what happens when these two worlds meet? More
The article challenges views that current patent legislation is inadequate to cover developments in the biological field. More
Patinnova and Epidos brought together entrepreneurs, industrialists and patent professionals providing a vigorous exchanges of views to give fresh evidence of the central but controversial role of IP in the 'new economy'. More
Displaying 1..10 of 13 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us